Aileron Therapeutics to Present at Two Upcoming Investor Conferences in August
WATERTOWN, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) — Aileron Therapeutics (NASDAQ:ALRN) today announced that Manuel Aivado, M.D., Ph.D., President and […]
Avis Budget Group Announces Intention to Offer $350 Million of Senior Notes
PARSIPPANY, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) — Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its […]
Intercept to Announce Second Quarter 2020 Financial Results on August 10, 2020
NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and […]
TRACON Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference
SAN DIEGO, Aug. 03, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the […]
RigNet Announces Second Quarter 2020 Earnings Release Date and Earnings Call Information
HOUSTON, Aug. 03, 2020 (GLOBE NEWSWIRE) — RigNet, Inc. (NASDAQ: RNET) today announced that it will release its second quarter […]
Catalyst Pharmaceuticals to Hold Second Quarter 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, August 11th, 2020
CORAL GABLES, Fla., Aug. 03, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused […]
Celldex to Report Second Quarter 2020 Financial Results and Host Corporate Update Call
HAMPTON, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (Nasdaq:CLDX) will report second quarter 2020 financial results on […]
Aileron Therapeutics Announces Completion of Enrollment in Dose Optimization Expansion Cohort of Proof-of-Concept Phase 1b Study of ALRN-6924
Study is evaluating ALRN-6924 to protect against chemotherapy-induced bone marrow toxicities in patients with p53-mutated small cell lung cancer (SCLC) […]
Cabaletta Bio to Present at Multiple August Investor Conferences
PHILADELPHIA, Aug. 03, 2020 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery […]
Melinta Therapeutics Announces Appointment of Christine Ann Miller as President and Chief Executive Officer
MORRISTOWN, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) — Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage company focused on the development and […]
